HBIO — Harvard Bioscience Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Harvard Bioscience Inc

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$5.40
Market Cap$24.9M
Float3.5M
Shares Outstanding4.5M
P/E (Forward)15.06
Price/Sales (TTM)0.29
vs. Analyst Target+11.1% to analyst PT
Profit Margin-65.51%
Operating Margin (TTM)14.01%
Revenue (TTM)$86.5M
Earnings Growth (YoY)-80.30%
Dividend RateNone
Analyst Target Price$6.00 (2 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $102M -$7.8M $58.0M $5.2M
2021 $119M -$288,000 $67.7M $9.0M
2022 $113M -$9.5M $60.8M $944,000
2023 $112M -$3.4M $66.1M $8.0M
2024 $94.1M -$12.4M $54.8M -$1.5M
2025 $86.5M -$56.7M $45.9M $5.3M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $20.4M -$2.3M
Sep 2025 $20.6M -$1.2M
Dec 2025 $23.7M -$2.8M
Mar 2026 $20.8M -$3.4M

Ownership & Float

Insider Ownership7.7%
Institutional Ownership49.7%
Short Float4.9%
% of All Funds Holding0.39%
Number of Funds Holding32

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$5.65Near-term / short-term trend
Weekly40-Week SMA$5.60Medium-term trend
Weekly80-Week SMA$7.87Cyclical trend (business cycle)
Weekly200-Week SMA$25.66Secular trend (multi-year)
Monthly10-Month SMA$5.67Near-term monthly trend
Monthly20-Month SMA$8.59Medium-term monthly trend
Monthly40-Month SMA$24.99Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$3.70 support 9.42x 11 months ago
$8.60 resistance 1.90x 13 months ago
$17.00 resistance 1.69x 14 months ago
$21.20 resistance 1.61x 15 months ago
$38.80 resistance 1.04x 23 months ago

Historical Earnings Reactions (101 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.05% 0.00% 49.50% 12.30% -27.95%
1 Day -0.76% -0.34% 40.59% 44.39% -45.03%
1 Week -1.69% -0.69% 44.55% 48.79% -48.30%
2 Weeks -2.10% -2.90% 45.00% 32.62% -46.78%
1 Month 1.12% -1.53% 44.00% 103.63% -48.72%

Next earnings: May 12, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-2.5%40.0%25
Feb0.7%52.0%25
Mar3.3%56.0%25
Apr1.7%42.3%26
May-5.6%28.0%25
Jun1.6%48.0%25
Jul1.6%60.0%25
Aug-0.1%36.0%25
Sep-2.1%44.0%25
Oct-1.1%56.0%25
Nov0.4%40.0%25
Dec7.3%72.0%25

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.06% 45.6% 1189
Tuesday 0.00% 44.3% 1299
Wednesday -0.03% 44.3% 1298
Thursday 0.17% 45.7% 1273
Friday 0.14% 46.9% 1269

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 49.7%

Insider Transactions — Smart Summary

Total insider ownership: 7.7%

12-Month Insider Activity Summary

Total Filings5
Net Value+$50,050
Net Shares Change-321,522
% of Float-9.2%
C-Suite Filings2
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Snider William +$103,603.5 1 1 buy
DENELSKY STEPHEN J +$48,700 1 1 buy
Duke John D Chief Executive Officer +$25,050 1 1 buy
Frost Mark T Chief Financial Officer +$25,000 1 1 buy
Green James W -$23,667.46 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-03-17 – 2026-03-18 3 3 +$177,353.5 1 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-01 Frost Mark T Chief Financial Officer +$25,000 Transaction at $5.00, now +8.0%
2026-03-17 Duke John D Chief Executive Officer +$25,050 Transaction at $5.01, now +7.8%
2026-03-18 Snider William +$103,603.5 Transaction at $4.93, now +9.5%
2026-03-18 DENELSKY STEPHEN J +$48,700 Transaction at $4.87, now +10.9%
2025-08-19 Green James W -$23,667.46 Transaction at $0.53, now +920.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Harvard Bioscience Inc (HBIO) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for HBIO on Trend Edge →